JPMorgan analyst Ryan Brinkman lowered the firm’s price target on Gentex (GNTX) to $28 from $29 and keeps a Neutral rating on the shares. The firm trimmed estimates post the Q4 report.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GNTX: